This is a non-core endpoint: only basic statistics are computed.
Melanoma in situ of upper limb, including shoulder
CD2_INSITU_MELANOMA_UPPERLIMB_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D03
- Name in latin
- Melanoma in situ regionis deltoideae
Similar endpoints
↥List of similar endpoints to
Melanoma in situ of upper limb, including shoulder
based on the number of shared cases.
Similar with more cases:
- Melanoma in situ of upper limb, including shoulder
- Melanoma in situ
- Melanoma in situ
- Malignant melanoma
- Malignant melanoma, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 223 | 131 | 92 |
| Unadjusted period prevalence (%) | 0.04 | 0.04 | 0.04 |
| Median age at first event (years) | 68.34 | 66.98 | 70.27 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 191
- Matched controls
- 1909
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D03.6
ICD-10 Finland
Melanoma in situ of upper limb, including shoulder
+∞
273.2
190
*
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
558.0
147.0
129
7
8720/2-C44.9
ICD-O-3
Melanoma in situ of skin, NOS
+∞
50.3
46
*
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
29.7
49.0
67
34
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
16.2
42.4
73
70
D22.6
ICD-10 Finland
Melanocytic naevi of upper limb, including shoulder
129.7
39.5
41
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
162.2
38.3
39
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
26.7
38.0
53
27
L57.0
ICD-10 Finland
Actinic keratosis
11.7
34.3
69
88
D22.5
ICD-10 Finland
Melanocytic naevi of trunk
20.0
33.3
51
34
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
22.3
30.7
45
26
D22.9
ICD-10 Finland
Melanocytic naevi, unspecified
19.8
30.1
46
30
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
26.7
25
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
25.6
24
*
TQW99
NOMESCO Finland
Other minor procedure on skin
18.1
23.7
37
25
ZZR00
NOMESCO Finland
Flap of skin
47.6
21.0
25
6
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
28.5
18.8
25
10
S18
ICPC
Laceration/cut
3.9
18.1
113
513
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
18.0
17
*
C43.62
ICD-10 Finland
Malignant melanoma of upper extremity including shoulder: 'superficial spreading' type
+∞
16.9
16
*
R23.8
ICD-10 Finland
Other and unspecified skin changes
5.2
16.9
59
152
S77
ICPC
Malignant neoplasm of skin
+∞
15.8
15
*
8720/3-C44.9
ICD-O-3
Malignant melanoma, NOS, of skin, NOS
+∞
15.8
15
*
D22.7
ICD-10 Finland
Melanocytic naevi of lower limb, including hip
41.9
15.7
19
5
SPAT1153
SPAT
Removal of sutures
3.5
13.9
89
383
D04.6
ICD-10 Finland
Carcinoma in situ: Skin of upper limb, including shoulder
+∞
13.7
13
*
8720/3-C44.6
ICD-O-3
Malignant melanoma, NOS, of skin of upper limb and shoulder
+∞
13.7
13
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
150.2
13.6
14
*
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
16.7
13.5
21
14
S82
ICPC
Naevus/mole
4.8
13.1
47
122
XQ846
NOMESCO Finland
Digital dermatoscopy and registration of nevi
+∞
12.6
12
*
D03.5
ICD-10 Finland
Melanoma in situ of trunk
138.7
12.6
13
*
D06BB10
ATC
imiquimod; topical
10.7
12.1
23
24
C43.60
ICD-10 Finland
Malignant melanoma of the upper extremity including the shoulder without histology
+∞
11.6
11
*
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
+∞
11.6
11
*
C43.6
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of upper limb, including shoulder
+∞
11.6
11
*
115
Kela drug reimbursment
Breast cancer
+∞
11.6
11
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
11.6
11
*
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
21.7
11.3
16
8
ZXC50
NOMESCO Finland
Cryotherapy
13.0
11.1
19
16
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
63.6
10.7
12
*
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
15.4
10.7
17
12
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
116.1
10.5
11
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
10.5
10
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
+∞
10.5
10
*
8720/3-C44.5
ICD-O-3
Malignant melanoma, NOS, of skin of trunk
+∞
9.4
9
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
9.4
9
*
C43.59
ICD-10 Finland
Malignant melanoma of the trunk other or unspecified histology
+∞
9.4
9
*
C43.69
ICD-10 Finland
Malignant melanoma of the upper extremity including shoulder other or unspecified histology
+∞
9.4
9
*
C43
ICD-10 Finland
Malignant melanoma of skin
+∞
9.4
9
*
L82
ICD-10 Finland
Seborrhoeic keratosis
3.3
9.3
51
188
XX3DW
NOMESCO Finland
Time consuming IT work
7.5
9.1
21
31
H02AB02
ATC
dexamethasone; systemic
38.7
9.1
11
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
15.0
8.8
14
10
ZXC15
NOMESCO Finland
Use of photodynamic technique
52.4
8.8
10
*
ZXC20
NOMESCO Finland
Use of chemical agents
29.0
8.6
11
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
8.4
8
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
8.4
8
*
8743/3-C44.9
ICD-O-3
Low cumulative sun damage melanoma of skin, NOS
+∞
8.4
8
*
8720/2-C44.6
ICD-O-3
Melanoma in situ of skin of upper limb and shoulder
+∞
8.4
8
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
8.4
8
*
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
19.3
7.7
11
6
QXE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in uspecified region
83.2
7.5
8
*
ZZA50
NOMESCO Finland
Full thickness skin graft
83.2
7.5
8
*
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
+∞
7.3
7
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
7.3
7
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
7.3
7
*
C43.72
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip: 'superficial spreading' type
+∞
7.3
7
*
D04.4
ICD-10 Finland
Carcinoma in situ: Skin of scalp and neck
+∞
7.3
7
*
A04AA02
ATC
granisetron; systemic, transdermal
+∞
7.3
7
*
D03.7
ICD-10 Finland
Melanoma in situ of lower limb, including hip
+∞
7.3
7
*
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
16.6
7.3
11
7
XQ845
NOMESCO Finland
Dermatoscopy
21.0
7.2
10
5
ZZA00
NOMESCO Finland
Split skin graft
9.3
7.2
14
16
WX408
NOMESCO Finland
General anesthesy, balanced
2.6
6.9
56
261
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
17.5
6.8
10
6
QBE99
NOMESCO Finland
Other excision or repair of lesion of skin of trunk
23.5
6.7
9
*
WX110
NOMESCO Finland
Local anesthesy
2.3
6.7
133
957
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
4.8
6.4
20
45
C44.81
ICD-10 Finland
Overall basocellular carcinoma of the skin
+∞
6.3
6
*
D22.0
ICD-10 Finland
Melanocytic naevi of lip
+∞
6.3
6
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
6.3
6
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
6.3
6
*
C43.50
ICD-10 Finland
Malignant melanoma of the torso without histology
+∞
6.3
6
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
6.3
6
*
130
Kela drug reimbursment
Malignant tumour
+∞
6.3
6
*
QAE20
NOMESCO Finland
Excision and repair of scar or web of skin of head or neck
+∞
6.3
6
*
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
6.3
6
*
XQ848
NOMESCO Finland
Dermatological photography
9.1
6.2
12
14
EP1AE
NOMESCO Finland
Neck ultrasound examination
5.9
6.1
16
29
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3002256) Pathology report gross observation
119
125
19.27
112.39
2.0
1.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
183
551
13.94
69.82
4.3
1.6
—
—
—
0
0
(4035726)
54
39
17.95
60.90
1.7
1.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
33
68
5.52
15.77
1.5
1.3
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
135
864
2.43
9.37
6.1
5.1
mmol/l
1.2
1.2
0.38
112
742
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
125
795
2.30
8.51
6.1
4.6
mmol/l
1.2
1.2
0.46
111
715
(42870588) Differential panel, method unspecified - Blood
94
548
2.24
7.70
5.9
5.2
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
97
576
2.21
7.57
4.0
2.1
mmol/l
2.3
2.4
0.50
74
482
(3019225) pH of Specimen
37
160
2.57
5.81
3.5
3.5
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
110
738
1.97
5.77
2.7
2.3
nmol/l
85.4
77.9
1.96
88
649
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
110
748
1.93
5.46
4.2
3.5
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
13
30
4.54
5.37
2.2
1.3
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
47
236
2.26
5.31
4.8
2.6
mmol/l
0.8
0.8
0.32
40
220
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
33
143
2.53
5.15
2.6
3.5
ng/l
84.2
82.4
0.06
21
123
(3044640) Blood type and Crossmatch panel - Blood
79
489
1.95
5.11
3.1
1.9
—
—
—
0
0
(3018418) pH of Serum or Plasma
83
523
1.94
5.09
5.1
3.1
ph
7.4
7.4
0.25
18
87
(3021589) Normoblasts [#/volume] in Blood
108
760
1.82
4.57
10.9
7.9
e9/l
0.0
0.0
0.24
84
609
(3013650) Neutrophils [#/volume] in Blood by Automated count
127
940
1.82
4.53
8.4
6.3
e9/l
4.0
4.2
0.42
102
820
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
198
1708
2.42
4.36
18.0
11.4
ml/min/173m2
77.0
76.3
0.17
177
1366
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
10
22
4.71
4.35
1.1
1.5
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
106
754
1.77
4.24
6.3
5.0
%
0.7
0.7
0.19
100
695
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
165
1346
1.87
4.05
8.6
5.1
u/l
74.2
75.9
0.30
150
1235
(3013707) Erythrocyte sedimentation rate by Westergren method
166
1365
1.85
3.87
4.7
4.0
mm/h
11.4
12.3
0.34
147
1245
(3001604) Monocytes [#/volume] in Blood
114
843
1.72
3.87
6.0
4.9
e9/l
0.6
0.6
0.05
88
724
(3024561) Albumin [Mass/volume] in Serum or Plasma
102
733
1.72
3.83
5.0
3.2
g/l
35.2
35.5
0.24
90
685
(3006504) Eosinophils/100 leukocytes in Blood
107
781
1.71
3.78
6.2
5.0
%
2.6
3.0
1.19
101
723
(3006315) Basophils [#/volume] in Blood
114
849
1.70
3.72
6.0
4.9
e9/l
0.0
0.0
0.19
89
730
(40768793) Breast Pathology biopsy report
9
16
5.81
3.69
1.3
1.1
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
107
785
1.70
3.68
6.3
5.3
%
8.8
8.5
0.44
100
730
(3013115) Eosinophils [#/volume] in Blood
116
878
1.67
3.49
6.4
5.2
e9/l
0.2
0.2
1.16
91
772
(3009542) Hematocrit [Volume Fraction] of Blood
184
1582
1.93
3.48
19.0
14.0
%
39.3
39.6
0.15
125
1075
(3021960) Folate [Moles/volume] in Serum or Plasma
72
480
1.74
3.47
1.6
1.5
nmol/l
24.0
21.8
0.40
55
410
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
51
308
1.85
3.41
3.7
2.7
ug/l
0.8
0.8
0.09
33
206
(3019198) Lymphocytes [#/volume] in Blood
114
866
1.65
3.33
6.2
4.9
e9/l
1.8
1.9
0.07
91
758
(3018010) Neutrophils/100 leukocytes in Blood
107
800
1.65
3.33
5.9
4.9
%
58.6
57.2
0.69
101
747
(3002030) Lymphocytes/100 leukocytes in Blood
107
803
1.64
3.26
6.3
5.2
%
26.7
28.0
0.67
101
741
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
11
34
3.35
3.10
2.1
1.3
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
41
240
1.87
3.01
5.4
4.8
%
34.2
32.2
0.45
19
154
(3032080) INR in Blood by Coagulation assay
98
733
1.60
2.95
14.4
9.8
inr
1.4
1.4
0.03
29
200
(40768795) Lymph node Pathology biopsy report
5
6
8.49
2.76
1.2
1.0
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
113
884
1.56
2.75
6.8
3.6
umol/l
10.0
11.5
2.03
105
826
(3012441) Differential panel - Pleural fluid
6
10
6.13
2.71
1.7
1.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
9
24
3.86
2.70
1.4
1.3
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
56
372
1.67
2.67
3.4
1.9
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
209
1924
2.37
2.63
12.5
8.7
u/l
24.9
24.4
0.20
197
1839
(3000494) Fungus identified in Specimen by Culture
34
197
1.86
2.58
1.9
1.5
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
5
7
7.27
2.56
1.8
1.3
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
197
1784
1.89
2.46
5.1
4.7
mmol/l
1.5
1.5
0.18
162
1638
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
202
1845
2.01
2.44
5.5
5.3
mmol/l
2.7
2.7
0.19
170
1698
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
104
814
1.52
2.44
2.2
2.0
pmol/l
90.3
94.7
0.34
46
388
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
198
1797
1.91
2.44
16.6
12.3
mg/l
20.3
21.7
0.20
167
1387
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
192
1727
1.80
2.43
6.4
6.3
mmol/mol
38.8
40.3
2.26
162
1604
(3002582) Erythrocytes [#/volume] in Urine
75
547
1.56
2.43
4.1
2.9
e6/l
18.8
170.0
0.67
56
407
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
8
22
3.73
2.38
2.0
1.2
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
5
8
6.36
2.38
2.0
1.0
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
5
8
6.36
2.38
1.0
1.1
u/l
19.6
17.3
—
5
8
(3045788) Cell count panel - Pleural fluid
5
8
6.36
2.38
2.0
1.1
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
5
8
6.36
2.38
1.4
1.4
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
198
1802
1.88
2.34
4.9
4.7
mmol/l
4.7
4.6
0.47
166
1660
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
188
1686
1.73
2.34
6.5
4.7
mu/l
1.8
2.7
0.61
164
1525
(36304419) Bacteria [Presence] in Urine
68
489
1.56
2.33
3.8
2.7
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
207
1914
2.14
2.30
19.3
14.7
umol/l
80.9
78.7
0.38
207
1914
(3030467) Casts [#/volume] in Urine by Automated count
69
500
1.55
2.28
3.9
2.8
e6/l
1.2
0.5
0.37
52
360
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
198
1807
1.85
2.25
5.2
4.8
mmol/l
5.8
6.0
1.05
161
1640
(3013512) EKG study
77
577
1.51
2.17
4.0
4.0
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
45
298
1.64
2.16
2.9
2.8
e6/l
3.0
2.7
0.10
24
152
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
9
31
2.98
2.09
1.9
1.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
29
171
1.80
2.09
1.2
1.3
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
16
76
2.19
2.08
1.4
1.9
g/l
1.1
1.5
0.89
11
65
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
6
15
4.08
2.05
15.3
6.3
mg/l
11.3
12.3
—
6
15
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
9
32
2.89
2.02
1.2
1.3
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
31
189
1.74
2.01
1.7
1.7
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
83
641
1.47
1.99
4.4
2.9
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
83
641
1.47
1.99
5.0
3.5
e6/l
36.7
101.5
2.04
60
444
(40758558) Short blood count panel - Blood
56
400
1.53
1.95
6.3
4.7
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
202
1871
1.85
1.95
16.3
11.8
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
189
1720
1.65
1.94
4.7
4.2
mmol/l
1.3
1.3
0.45
152
1561
(3037467) Urinalysis macro (dipstick) panel - Urine
142
1219
1.45
1.92
5.1
4.3
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
204
1897
1.88
1.91
20.1
15.2
mmol/l
4.0
4.0
0.52
199
1834
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
8
28
2.92
1.88
3.4
3.0
%
55.5
57.7
—
8
28
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
8
28
2.92
1.88
2.0
1.3
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
74
566
1.46
1.85
3.0
3.1
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
50
353
1.54
1.83
3.3
2.1
mmol/l
2.5
2.4
1.87
43
305
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
5
12
4.24
1.83
1.8
1.3
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
8
29
2.82
1.81
7.5
2.7
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
37
245
1.61
1.78
2.2
1.7
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
18
96
1.95
1.76
3.3
1.6
ug/l
2.2
5.6
0.61
11
76
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
35
230
1.62
1.73
4.4
7.2
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
5
13
3.91
1.72
1.6
1.1
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
45
315
1.54
1.71
2.8
2.5
e6/l
0.8
1.2
0.60
24
168
(3049717) Cytology report of Urine Cyto stain
12
55
2.25
1.70
2.1
1.6
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
28
426
0.61
1.68
4.4
3.9
kg/l
1.0
1.0
—
6
65
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
11
49
2.31
1.66
2.1
3.8
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
5
14
3.63
1.62
2.4
1.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
5
14
3.63
1.62
1.4
1.1
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
63
478
1.44
1.62
3.4
2.4
umol/l
6255.3
10723.8
0.30
57
411
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
6
20
3.05
1.59
2.3
1.2
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
156
1388
1.41
1.56
5.4
3.8
pmol/l
15.1
14.9
0.38
130
1253
(3030905) Polymorphonuclear cells [#/volume] in Blood
7
27
2.64
1.52
2.7
2.3
e9/l
3.8
4.6
—
7
27
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
14
72
2.01
1.52
2.3
2.6
u/l
39.4
41.8
0.18
14
63
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
118
1006
1.37
1.51
2.9
2.8
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
40
281
1.52
1.50
2.0
1.7
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
74
588
1.39
1.45
2.7
2.0
u/l
297.5
176.4
0.60
66
549
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
5
16
3.17
1.44
1.0
1.1
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
52
392
1.43
1.37
3.0
1.7
mg/l
0.9
1.1
0.23
40
297
(3026782) Osmolality of Urine
48
357
1.44
1.36
3.5
2.4
mosm/kgh2o
504.9
541.8
0.81
43
296
(40761536) Microorganisms panel - Urine sediment
22
137
1.67
1.35
6.0
3.4
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
9
42
2.19
1.35
1.0
1.8
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
130
1139
1.34
1.33
4.0
2.9
u/l
50.9
45.2
0.37
117
1060
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
10
190
0.50
1.31
2.0
1.6
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
57
441
1.39
1.30
4.8
3.9
%
20.3
24.5
2.32
28
211
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
12
62
1.99
1.30
1.9
1.5
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
122
1062
1.33
1.29
4.2
3.8
mmol/l
6.5
6.7
0.47
117
986
(3023368) Bacteria identified in Blood by Culture
57
442
1.39
1.28
4.9
3.7
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
18
108
1.73
1.26
1.7
1.7
—
—
—
0
0
(1616796) Gas panel - Central venous blood
8
36
2.27
1.25
5.3
2.9
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
6
25
2.44
1.25
1.0
1.0
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
11
56
2.01
1.24
1.9
1.5
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
20
125
1.66
1.22
13.6
6.6
mmol/l
14.3
10.6
0.67
20
118
(3044889) 12 lead EKG panel
142
1269
1.33
1.22
4.0
4.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
5
19
2.67
1.22
1.2
1.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
6
26
2.34
1.19
2.2
1.4
—
—
—
0
0
(3022313) Gas panel - Capillary blood
13
72
1.86
1.17
2.3
4.0
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
7
33
2.16
1.06
1.3
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
7
33
2.16
1.06
1.3
1.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
22
147
1.55
1.05
1.6
1.5
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
9
46
2.00
1.05
1.7
1.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
5
109
0.45
1.03
1.0
1.4
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
9
47
1.95
1.03
1.7
1.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
9
49
1.87
1.00
1.0
1.6
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
23
2.20
0.98
1.0
1.1
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
0
31
0.00
0.97
0.0
2.2
—
105.1
—
0
31
(3041354) Potassium [Moles/volume] in Venous blood
0
31
0.00
0.97
0.0
2.2
—
4.1
—
0
31
(3033705) Calcium.ionized [Moles/volume] in Venous blood
0
31
0.00
0.97
0.0
2.2
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
26
185
1.46
0.94
3.3
3.0
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
6
27
2.26
0.94
1.0
1.0
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
32
238
1.40
0.93
1.8
1.4
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
61
502
1.30
0.92
1.5
1.6
mmol/l
1.3
1.3
0.02
46
419
(3018677) aPTT in Platelet poor plasma by Coagulation assay
36
275
1.37
0.90
3.9
1.6
s
32.1
29.3
1.51
36
262
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
41
321
1.34
0.88
1.4
1.3
iu/ml
23.5
36.1
0.57
11
95
(3002179) Metamyelocytes/100 leukocytes in Blood
16
104
1.58
0.87
4.8
4.0
%
0.8
0.3
—
6
19
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
68
572
1.27
0.87
5.9
4.0
ug/l
11.4
2.0
0.50
58
509
(3024354) Oxygen [Partial pressure] in Venous blood
8
139
0.56
0.86
2.9
2.5
kpa
4.0
4.6
—
8
130
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
6
114
0.51
0.85
1.3
1.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
24
172
1.44
0.85
1.6
1.5
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
6
31
1.96
0.85
5.0
2.4
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
15
97
1.59
0.83
3.4
3.7
mmol/l
1.6
2.4
—
8
67
(3025159) Blasts/100 leukocytes in Blood
16
108
1.52
0.76
5.3
3.9
%
0.1
4.4
—
7
20
(3001122) Ferritin [Mass/volume] in Serum or Plasma
84
735
1.23
0.75
3.3
2.7
ug/l
185.4
114.6
1.29
74
674
(3000330) Specific gravity of Urine by Test strip
6
108
0.54
0.74
4.2
3.4
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
38
1.87
0.74
1.0
1.1
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
53
443
1.26
0.71
2.6
2.1
mg/l
2.9
3.1
0.23
35
368
(3021440) Promyelocytes/100 leukocytes in Blood
16
110
1.49
0.70
5.2
4.0
%
0.1
0.1
—
7
22
(3023183) Ammonium ion [Moles/volume] in Plasma
5
28
1.80
0.66
2.2
2.1
umol/l
28.2
36.2
—
5
21
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
25
191
1.35
0.64
2.0
2.1
umol/l
9.3
7.4
0.17
19
162
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
12
79
1.55
0.64
7.8
7.3
mmol/l
26.4
24.8
0.46
12
71
(3027945) Reticulocytes/100 erythrocytes in Blood
27
210
1.33
0.62
3.1
2.3
%
1.7
1.7
0.04
22
190
(3039443) Prostate specific Ag panel - Serum or Plasma
5
30
1.68
0.62
1.2
1.5
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
5
30
1.68
0.62
1.4
1.5
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
8
53
1.53
0.59
4.5
3.4
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
16
116
1.41
0.56
5.3
3.9
%
2.1
0.8
—
7
25
(3023520) Reticulocytes [#/volume] in Blood
21
160
1.34
0.56
2.3
2.4
e9/l
58.2
67.3
0.94
11
131
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
6
38
1.59
0.54
1.0
1.2
mmol/l
3.9
3.9
—
6
33
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
11
74
1.51
0.54
1.4
1.2
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
24
188
1.31
0.54
4.9
5.6
mmol/l
2.6
1.6
0.41
18
148
(3021879) Hepatitis B virus core Ab [Presence] in Serum
12
83
1.47
0.53
1.2
1.5
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
26
208
1.28
0.51
1.8
1.7
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
15
110
1.39
0.50
1.4
1.5
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
7
48
1.47
0.47
10.1
2.3
mg/l
2.4
1.6
—
7
40
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
7
49
1.44
0.46
1.3
1.2
—
—
—
0
0
(3000991) Gas panel - Venous blood
17
131
1.32
0.43
5.7
6.3
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
8
56
1.44
0.43
1.5
1.8
ug/l
2.9
2.4
—
8
49
(40760892) CBC W Ordered Manual Differential panel - Blood
41
354
1.19
0.42
5.9
3.9
—
—
—
0
0
(3017704) Immunofixation for Urine
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
9
67
1.36
0.38
7.6
7.0
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
44
386
1.17
0.38
5.2
4.0
ng/l
248.4
235.2
0.03
38
321
(3003694) ABO and Rh group [Type] in Blood
47
416
1.16
0.37
1.5
1.4
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
13
99
1.33
0.36
3.8
2.8
e6/l
0.3
0.2
0.23
13
94
(3000475) Leukocytes [#/volume] in Synovial fluid
6
42
1.44
0.36
1.8
1.6
e6/l
15175.0
16009.3
—
6
28
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
63
572
1.14
0.35
2.8
2.1
u/l
55.0
58.6
0.29
54
521
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
6
46
1.31
0.33
1.5
1.2
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
15
119
1.28
0.32
1.3
1.4
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
30
259
1.18
0.32
1.2
1.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
7
97
0.71
0.31
1.3
1.4
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
34
298
1.17
0.30
1.5
1.2
u/ml
16.9
8.2
0.28
11
101
(3009508) Creatinine [Moles/volume] in Urine
67
617
1.12
0.30
4.0
3.0
mmol/l
7.2
7.5
0.20
48
510
(3029937) Albumin [Presence] in Urine by Test strip
43
476
0.88
0.28
5.4
3.9
estimate
0.0
0.0
0.00
24
146
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
8
64
1.26
0.28
1.5
1.6
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
24
206
1.18
0.27
1.9
1.7
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
14
113
1.25
0.27
2.4
2.5
—
—
—
0
0
(1002224) Polysomnography panel
8
67
1.20
0.26
1.0
1.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
64
689
0.90
0.26
4.3
3.8
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
10
127
0.78
0.26
1.2
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
13
105
1.25
0.25
1.7
1.9
—
—
—
0
0
(4010399)
11
137
0.79
0.25
2.0
1.4
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
58
536
1.11
0.25
3.2
2.4
u/l
29.0
32.8
0.81
53
506
(3012516) Albumin [Mass/volume] in Urine
64
595
1.11
0.24
3.8
3.2
mg/l
19.8
157.5
0.70
34
382
(3045414) Leukocytes [Presence] in Urine
9
77
1.18
0.24
2.2
1.9
—
—
—
0
0
(3022621) pH of Urine by Test strip
12
147
0.81
0.24
2.1
2.8
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
2.4
—
49.5
—
0
6
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
0
10
0.00
0.21
0.0
2.8
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
12
0.00
0.21
0.0
4.3
—
—
—
0
0
(3003338) MCHC [Mass/volume]
146
1502
0.92
0.21
22.4
16.7
g/l
332.1
332.0
0.06
146
1492
(4211845)
0
13
0.00
0.21
0.0
4.1
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
73
772
0.92
0.20
3.1
3.7
ng/l
20.8
40.7
2.77
54
550
(3034770) Mitochondria Ab [Titer] in Serum
6
48
1.26
0.20
1.0
1.2
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
6
52
1.16
0.19
1.8
1.2
—
2.9
—
0
9
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
6
53
1.14
0.19
1.8
1.2
—
10.9
—
0
11
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
7
58
1.21
0.18
1.9
1.8
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
7
61
1.15
0.17
1.1
1.0
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
5
68
0.73
0.17
1.4
1.8
—
132.0
—
0
5
(3041096) Erythrocytes [Presence] in Urine by Automated
52
489
1.08
0.16
3.7
3.4
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
23
207
1.12
0.15
2.0
1.8
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
7
86
0.81
0.15
1.6
1.5
g/l
1.0
1.2
—
7
79
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
39
364
1.09
0.14
1.3
1.3
u/ml
0.9
1.5
0.49
13
102
(3013139) Helicobacter pylori Ag [Presence] in Stool
14
122
1.16
0.14
1.3
1.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
66
630
1.07
0.14
5.3
3.9
mg/mmol
4.1
7.3
1.00
35
394
(3005322) IgE [Units/volume] in Serum or Plasma
8
97
0.82
0.14
1.0
1.2
u/ml
39.7
209.6
—
8
90
(3037522) Nuclear Ab [Titer] in Serum
23
209
1.11
0.13
1.5
1.4
titre
825.0
529.1
—
8
57
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
9
110
0.81
0.13
1.7
1.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
59
618
0.94
0.13
3.5
3.2
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
91
882
1.05
0.11
4.1
3.7
estimate
0.0
0.0
0.00
24
152
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
12
135
0.88
0.10
3.1
1.9
ml/min/173m2
41.5
58.9
—
6
47
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
5
48
1.04
0.09
1.2
1.3
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
6
56
1.07
0.08
4.0
4.3
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
91
889
1.04
0.08
5.5
5.1
estimate
0.0
0.0
0.00
24
149
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
24
255
0.93
0.07
1.6
1.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
7
80
0.87
0.07
1.0
1.0
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
9
88
1.02
0.07
1.8
1.3
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
64
622
1.04
0.07
2.4
3.1
ng/l
2108.7
1441.9
0.42
54
524
(3011397) Hemoglobin [Presence] in Urine by Test strip
40
416
0.95
0.06
3.9
3.7
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
13
120
1.09
0.05
2.0
2.0
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
21
200
1.06
0.04
6.2
5.0
mmol/l
102.8
104.3
0.57
21
195
(3025941) Bacteria identified in Stool by Culture
10
92
1.09
0.03
1.7
1.3
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
13
138
0.94
0.02
7.2
5.1
mmol/l
1.4
1.4
0.00
13
131
(3009261) Glucose [Presence] in Urine by Test strip
91
900
1.02
0.02
4.0
3.8
estimate
0.0
0.0
0.00
26
145
(3015736) pH of Urine
71
701
1.02
0.02
3.7
3.5
—
—
—
0
0
(3019060) Gas panel - Arterial blood
12
113
1.07
0.02
1.8
3.8
—
—
—
0
0
(3012544) pH of Venous blood
17
177
0.96
0.01
2.2
3.2
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
30
307
0.97
0.01
1.4
1.3
g/l
3.3
2.7
0.33
16
170
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
41
417
0.98
0.01
1.9
1.8
pmol/l
428.5
437.1
0.06
26
335
(40761535) Cells panel - Urine sediment
14
146
0.96
0.00
4.0
2.9
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
16
166
0.96
0.00
2.3
3.1
kpa
6.5
5.8
0.99
16
159
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
13
127
1.03
0.00
1.7
1.7
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
17
167
1.02
0.00
2.2
3.1
mmol/l
2.5
2.2
0.12
12
133
(3000492) Spirometry study
13
133
0.98
0.00
2.2
1.5
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
40
397
1.01
0.00
2.1
1.7
nmol/l
1037.0
1238.8
0.76
24
295
(3019832) Treponema pallidum Ab [Presence] in Serum
11
105
1.05
0.00
1.6
1.4
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
9
0.00
0.00
0.0
12.7
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4015189)
0
9
0.00
0.00
0.0
3.2
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
19.2
—
1658.4
—
0
9
(3051101) Glucose [Moles/volume] in Cord blood
0
7
0.00
0.00
0.0
4.7
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
5
58
0.86
0.00
2.6
2.0
—
—
—
0
0
(3008898) HLA-B27 [Presence]
5
58
0.86
0.00
1.0
1.1
—
—
—
0
0
(4198724)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
11.0
—
1065.2
—
0
9
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3048879) Bone marrow aspiration report
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
0
5
0.00
0.00
0.0
6.0
—
27.2
—
0
5
(3034426) Prothrombin time (PT)
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
6
63
0.95
0.00
1.0
1.1
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
6
62
0.97
0.00
1.0
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
0.4
—
0
6
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(4094501)
5
55
0.91
0.00
1.0
1.1
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
6
63
0.95
0.00
1.0
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
6
60
1.00
0.00
2.3
2.0
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
8
0.00
-0.00
0.0
1.0
—
9.9
—
0
8
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
8
0.00
-0.00
0.0
1.4
—
84.2
—
0
8
(3037556) Urate [Mass/volume] in Serum or Plasma
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_INSITU_MELANOMA_UPPERLIMB_EXALLC – Melanoma in situ of upper limb, including shoulder
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).